Registered LNG-EC products:
- Levonelle 1500* - Available directly from pharmacist without prescription (i.e. BTC)
- Levonelle-1* - Available directly from pharmacist without prescription (i.e. BTC)
- Norlevo-1* - Available directly from pharmacist without prescription (i.e. BTC)
- Postinor 1* - Available directly from pharmacist without prescription (i.e. BTC)
- Postinor-2* - Available directly from pharmacist without prescription (i.e. BTC)
Registered UPA-EC products:
- ellaOne* - Available directly from pharmacist without prescription (i.e. BTC)
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Public sector clinics, Pharmacies, Emergency room
Age restrictions for accessing ECPs: No
Legal/regulatory documents in which EC is included: No data available
Pricing information: LNG Products: $10.25-37.30 (11-40 AUD), as of August 2014.
Other relevant information: While community pharmacists are not required by law to ask specific questions prior to supplying LNG-EC in Australia, questioning may occur in practice. The Pharmaceutical Society of Australia supports increased access for young women with no specific restrictions on third party supply and advanced supply. Access can be limited in rural areas if the only pharmacist in town has a conscientious objection to supplying the LNG-ECP and there is no alternative supplier nearby.
There are no legal age restrictions for supplying ECPs, but many pharmacists may prefer to refer women under 16 years of age to a doctor rather than provide it themselves over the counter.
Copper IUDs are potentially available but access is limited.